NOI to Sole Source PhysioMimix Organ-on-a-Chip systems

ute of Infectious Diseases (USAMRIID), to CN Bio Innovations Limited, under the authority of 41 USC 1901, as implemented in Revolutionary FAR Overhaul (RFO) 12.102 -- Restricting competition and RFO 12.201-1 � Simplified procedures. This requirement is for the delivery of PhysioMimix Organ-on-a-Chip

systems and associated consumables/components compatible with the existing PhysioMimix systems currently in place at USAMRIID. While similar equipment and consumables may be available from other vendors, the other PhysioMimix systems in th